Swine Brucellosis: Disease Overview and Management
Understanding bacterial infection in pigs and control strategies

Understanding the Causative Agent
Brucella suis is the bacterial pathogen responsible for swine brucellosis, a chronic infectious disease that impacts reproductive health and general wellbeing in pig populations. This gram-negative, intracellular bacterium establishes persistent infections in the reproductive tract of affected animals, leading to significant economic losses in commercial swine operations. The organism is particularly adept at surviving in hostile environments and can maintain infectivity in bodily fluids and tissues for extended periods, making transmission and persistence in herds a considerable challenge for disease management.
The disease has been documented across numerous countries and remains a concern for swine producers worldwide. Unlike some bacterial infections that produce acute illness, brucellosis in pigs often manifests as a chronic condition with insidious onset, making early detection difficult without active laboratory surveillance. The organism’s ability to evade the immune system and establish latency in reproductive tissues explains why infected animals frequently remain infectious long after initial exposure.
Clinical Manifestations Across Different Age Groups
The presentation of brucellosis varies considerably depending on the age and sex of affected animals. Understanding these differences is critical for identifying potentially infected individuals within a herd.
Reproductive Disorders in Breeding Animals
Female pigs demonstrate reproductive dysfunction as the primary clinical sign, with abortion occurring at any gestational stage. Infected sows experience vulval discharges containing purulent material, sometimes accompanied by blood, and develop bacteremia during the acute phase of infection. Importantly, the infection in female reproductive tracts is typically temporary, with most animals eventually clearing the infection spontaneously through immune response mechanisms.
Male pigs present with marked testicular pathology. Orchitis, characterized by swollen and painful testicles, represents a defining clinical sign in boars. Unlike sows, the reproductive tract infection in males tends to persist indefinitely, resulting in permanent tissue damage that cannot be reversed. This distinction is particularly significant for breeding programs, as infected boars remain sources of transmission through contaminated semen despite therapeutic intervention attempts.
Skeletal and Neurological Manifestations
Lameness emerges as a prominent clinical feature in growing and adult pigs, resulting from arthritis and joint inflammation. The disease can affect multiple joints, leading to reduced mobility and impaired productivity. In some cases, animals develop posterior paralysis, representing more severe neurological involvement that can render animals unable to stand or ambulate effectively. These manifestations result from bacterial seeding of joint tissues and spinal structures, creating inflammatory lesions that damage cartilage and bone.
Age-Specific Clinical Presentations
Piglets infected in utero may not survive gestation or are born weak and nonviable. Neonatal mortality increases significantly in offspring of infected dams. Weaners and grower pigs demonstrate swollen testicles and lameness as primary signs, with females showing high return to service rates and delayed estrous cycles indicating subfertility. Adult animals may exhibit only subtle signs, including marginally reduced birthing rates or unexpected return to heat after breeding attempts, making identification without laboratory testing challenging.
Transmission Pathways and Epidemiology
Understanding how brucellosis spreads within pig populations is essential for implementing effective control measures. The organism disseminates through multiple routes, making prevention particularly challenging in intensively managed herds.
Direct transmission occurs during breeding when contaminated semen from infected boars contacts reproductive tissues of susceptible females. This represents the most common transmission route in actively breeding herds. Horizontal transmission among non-breeding animals involves ingestion, inhalation, or ocular contact with bacteria present in milk, reproductive fluids, placental tissues, aborted fetuses, and urine. Piglets may acquire infection through consumption of contaminated colostrum or milk from infected dams, though most clear the infection during the first months of life.
Environmental contamination plays a significant role in persistence and spread. Brucella survives in reproductive fluids and fetal tissues, creating biosafety hazards during handling of infected materials. The organism can penetrate intact or compromised skin, enter through mucous membranes, and establish systemic infection following exposure. This reality makes post-mortem examination particularly hazardous, as the bacteria remain widely distributed throughout tissues even in chronic cases.
Diagnostic Approaches
Accurate diagnosis requires integration of clinical observations with laboratory confirmation, as many infected animals show minimal or no visible signs of illness.
Serological Testing Methods
Serologic testing has become the practical standard for diagnosing swine brucellosis due to limitations with bacterial culture approaches. Multiple serological techniques are employed depending on laboratory capabilities and regulatory requirements:
- Serum agglutination test (SAT): A foundational method where agglutination at titers greater than 31IU indicates positive status in EU trade standards
- Complement fixation test (CFT): Often used alongside SAT for export testing within the EU, with thresholds of 25IU or greater classified as positive
- Card and plate antigen tests: Rapid screening methods including the Rose Bengal test (RBT) used for preliminary herd assessment
- Enzyme-linked immunosorbent assay (ELISA): Competitive ELISA variants offering high sensitivity and specificity for detection of anti-Brucella antibodies
- Fluorescent polarization assay: Advanced technique providing rapid results with excellent accuracy for confirming infections
Sample Collection Strategies
Optimal sample selection enhances diagnostic accuracy. The most informative samples include aborted piglets, vaginal discharge swabs from affected females, tissues from dead pigs, and blood samples from at least ten sows—preferably those with recent abortion or estrous irregularities. Bacterial isolation from these materials remains the gold standard, though slow organism growth in vitro, reduced recovery rates from chronic infections, and biosafety concerns limit practical application in most field settings.
Diagnostic Challenges
Many infected swine demonstrate no apparent clinical illness upon visual inspection, rendering clinical diagnosis unreliable. Fever and reduced feed intake are typically absent, and routine blood count abnormalities are uncommon. The slow-growing nature of Brucella means that culture confirmation may require several weeks, necessitating repeat testing at intervals to establish definitive diagnosis through demonstration of seroconversion or bacterial growth.
Management and Control Strategies
Once brucellosis is confirmed in a herd, management decisions must balance disease control, economic considerations, and public health protection.
Treatment Efficacy and Limitations
Antibiotic therapy has demonstrated limited effectiveness in treating brucellosis in swine populations. While humans respond well to prolonged antibiotic courses combining doxycycline and rifampin for six weeks or longer, pigs rarely achieve clinical improvement following treatment. The intracellular persistence of the organism, chronic nature of the infection, and anatomical barriers to antibiotic penetration into reproductive tissues explain this therapeutic failure. Given poor treatment outcomes and continued infectivity of treated animals, affected pigs should be destroyed rather than subjected to ineffective medical management.
Herd-Level Control Approaches
The most reliable control method involves complete herd depopulation, facility decontamination, and restocking with brucella-free replacement animals. This approach eliminates all sources of infection, prevents ongoing transmission, and removes occupational hazards to pig handlers. While economically challenging, this strategy is generally the least expensive long-term solution compared to ongoing losses from reduced fertility, weak offspring, and labor costs associated with management of affected herds. In many jurisdictions, mandatory depopulation is required by regulatory authorities when brucellosis is confirmed.
Alternative approaches involving selective removal of test-positive animals are generally unsuccessful because latent infections may not be detected through serological screening, and environmental contamination persists despite removal efforts. Partial depopulation strategies prolong disease presence and transmission risks, ultimately delaying resolution of infection within the herd.
Biosecurity and Prevention
Prevention of introduction is vastly more effective than attempting eradication once established. Pig sources should be confirmed brucella-free through serological testing prior to introduction to the herd. Isolation facilities for new animals allow monitoring for clinical signs and serological conversion before integration into the main population. Strict biosecurity protocols prevent transmission from wild pig populations, which may harbor Brucella suis and represent ongoing infection reservoirs in some geographic regions.
Public Health Implications and Occupational Safety
Swine brucellosis represents a significant zoonotic hazard to individuals handling infected animals or their tissues. The organism readily infects humans through contact with abraded or broken skin, splashing onto mucous membranes, or inhalation of aerosolized bacteria from reproductive fluids and tissues. Occupational exposure risks are particularly acute during birthing assistance, post-mortem examination, or tissue processing.
Human brucellosis produces fever, joint pain, fatigue, and sweating that can persist for months or years. Infection can lead to chronic complications including arthritis, endocarditis, and depression. Early diagnosis and treatment with multi-drug antibiotic regimens for six to eight weeks can reduce morbidity, but recurrence is possible. These health risks underscore the importance of eliminating infected herds rather than attempting to manage the disease in affected populations.
Frequently Asked Questions
Can brucellosis in pigs be treated with antibiotics?
Treatment with antibiotics is generally ineffective in swine and is not recommended. Affected animals should be destroyed to eliminate infection sources and prevent transmission to humans and other pigs.
How quickly do clinical signs appear after exposure?
Clinical manifestations may develop within weeks of exposure, but some infected animals remain asymptomatic indefinitely, complicating early detection without laboratory testing.
What is the safest response when brucellosis is confirmed?
Complete herd depopulation, thorough facility decontamination, and restocking with certified brucella-free animals provides the most reliable long-term control and eliminates occupational health hazards.
Can boars recover from testicular infection?
No. Orchitis in male pigs typically results in permanent reproductive tissue damage that cannot be reversed, making infected boars lifelong sources of transmission.
Summary
Swine brucellosis, caused by Brucella suis, represents a serious threat to swine productivity, animal welfare, and human occupational health. The disease manifests through reproductive dysfunction, skeletal disease, and neurological complications varying by age and sex of affected animals. Diagnosis relies on serological testing supplemented by bacterial culture when feasible. Given the ineffectiveness of antibiotic therapy, the chronic and persistent nature of infection, and the zoonotic transmission risk to humans, depopulation of infected herds coupled with facility decontamination and restocking remains the most practical and economically sound control strategy. Prevention through testing of incoming breeding stock and maintenance of strong biosecurity measures protects herds from introduction of this devastating pathogen.
References
- Clinical Overview of Brucellosis — Centers for Disease Control and Prevention (CDC). 2024. https://www.cdc.gov/brucellosis/hcp/clinical-overview/index.html
- Swine Brucellosis — U.S. Department of Agriculture, Animal and Plant Health Inspection Service (USDA APHIS). https://www.aphis.usda.gov/livestock-poultry-disease/swine/swine-brucellosis
- Swine Brucellosis — Texas Animal Health Commission (TAHC). https://www.tahc.texas.gov/news/brochures/TAHCFactsheet_SwineBrucellosis.pdf
- Swine Brucellosis — Hawaii Department of Agriculture, Animal Industry Division. https://dab.hawaii.gov/ai/ldc/swine-brucellosis/
- Swine Brucellosis: Current Perspectives — National Center for Biotechnology Information (NCBI). PMC6042558. https://pmc.ncbi.nlm.nih.gov/articles/PMC6042558/
- Brucellosis: Symptoms & Causes — Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/brucellosis/symptoms-causes/syc-20351738
- Brucellosis: Causes, Symptoms, Treatment & Prevention — Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/17886-brucellosis
Read full bio of Sneha Tete








